Manuel Romero

ORCID: 0000-0003-2794-9710
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Lipoproteins and Cardiovascular Health
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Cancer, Lipids, and Metabolism
  • Liver Disease Diagnosis and Treatment
  • Health Systems, Economic Evaluations, Quality of Life
  • Lipid metabolism and disorders
  • Cardiac Imaging and Diagnostics
  • Hepatitis C virus research
  • Liver Disease and Transplantation
  • Coronary Interventions and Diagnostics
  • Vector-borne infectious diseases
  • Viral Infections and Vectors
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Urticaria and Related Conditions
  • Drug-Induced Hepatotoxicity and Protection
  • Biosimilars and Bioanalytical Methods
  • Hemoglobinopathies and Related Disorders
  • Skin Diseases and Diabetes
  • Hepatitis B Virus Studies
  • HIV-related health complications and treatments
  • Blood transfusion and management
  • Vasculitis and related conditions
  • Gastrointestinal disorders and treatments
  • Pharmaceutical Economics and Policy
  • Liver Diseases and Immunity

Hospital Universitario Infanta Leonor
2013-2024

Hospital Juan Ramón Jiménez
2023

Hospital Clínico Universitario Virgen de la Victoria
2004-2019

Hospital Universitario de Valme
1997-2017

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas
2017

Hospital Comarcal de Inca
2016

Hospital Universitario Virgen del Rocío
2012

Centro de Investigación Biomédica en Red
2008

Instituto de Salud Carlos III
2008

Diagnosis in the early stages of hereditary transthyretin (ATTR) amyloidosis is imperative to support timely treatment prevent or delay disease progression. Genetic testing setting genetic counselling enables identification carriers a TTR gene mutation who are therefore at risk developing TTR-associated disease. Knowledge different genotypes and how they manifest symptomatic should facilitate development structured targeted approach enable diagnosis ATTR on first manifestation earliest...

10.1080/13506129.2018.1556156 article EN Amyloid 2019-01-02

The effect of alirocumab, a PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitor, on coronary plaque burden in patients with familial hypercholesterolemia has not been addressed. Our aim was to assess changes and its characteristics after treatment alirocumab by quantification characterization atherosclerotic throughout the tree basis noninvasive analysis computed tomographic angiography asymptomatic subjects receiving optimized stable maximum tolerated statin dose or without...

10.1161/circulationaha.122.062557 article EN cc-by-nc-nd Circulation 2023-04-03

Direct-acting antiviral agents (DAAs) are highly effective and well tolerated in patients with chronic hepatitis C virus infection, including those compensated cirrhosis. However, fewer data available more advanced liver disease. Our retrospective, noninterventional, national, multicenter study from the Spanish Hepa-C registry investigated effectiveness safety of interferon-free DAA regimens disease, decompensated cirrhosis, routine practice (all currently approved were registered). Patients...

10.1002/hep.29097 article EN publisher-specific-oa Hepatology 2017-02-07

10.1016/j.jcmg.2021.06.011 article EN publisher-specific-oa JACC. Cardiovascular imaging 2021-07-14

Drug-induced idiosyncratic liver disease (DIILD) depends largely on host susceptibility factors. Small studies support the genetic influence of human leukocyte antigen (HLA) class II molecules predisposition to DIILD. We sought associations between HLA-DRB and -DQB alleles DIILD considered collectively or according biochemical expression damage. studied a total 140 patients with definitive probable diagnosis DIILD, as assessed Council for International Organizations Medical Sciences scale,...

10.1002/hep.20215 article EN Hepatology 2004-05-27

BACKGROUND The increasing incidence of osteoporotic hip fracture (HF) has raised the requirements red blood cell (RBC) transfusions, whereas this scarce resource may cause morbidity and mortality. STUDY DESIGN AND METHODS This study was a multicenter, randomized, double‐blind, clinical trial that aimed to assess efficacy ferric carboxymaltose (FCM) with or without erythropoietin (EPO) in reducing RBC transfusion perioperative period HF. Participants (patients > 65 years admitted HF...

10.1111/trf.13624 article EN Transfusion 2016-05-14

BACKGROUND: Intensive lipid-lowering therapy may induce coronary atherosclerosis regression. Nevertheless, the factors underlying effect of on disease regression remain poorly characterized. Our aim was to determine which characteristics atherosclerotic plaque are associated with a greater reduction in burden (PB) after treatment alirocumab patients familial hypercholesterolemia. METHODS: The ARCHITECT study (Effect Alirocumab Atherosclerotic Plaque Volume, Architecture and Composition) is...

10.1161/circimaging.123.016206 article EN Circulation Cardiovascular Imaging 2024-01-01

•This study analyzes event rates of 2 high-potency statins in FH.•LDL-C goal attainment and risk were similar both groups.•LDL-C reduction was greater with rosuvastatin. Events groups.•Event rate 1.1/100 patient-years atorvastatin 1.2 BackgroundMaximal doses potent are the basement treatment familial hypercholesterolemia (FH). Little is known about use different statin regimens FH.ObjectivesThe objectives to describe changes low-density lipoprotein cholesterol (LDL-C) achievement (ATV)...

10.1016/j.jacl.2019.10.005 article EN cc-by-nc-nd Journal of clinical lipidology 2019-10-12

10.1016/j.jacl.2018.07.013 article EN Journal of clinical lipidology 2018-08-01

Abstract Aims Knowledge of the features patients with familial hypercholesterolaemia (FH) who are protected from atherosclerotic cardiovascular disease (ASCVD) is important for clinical and prognostic care this apparently high-risk condition. Our aim was to investigate determinant characteristics FH ASCVD have normal life expectancy, so-called ‘resilient’ (R-FH). Methods results Spanish Familial Hypercholesterolaemia cohort study (SAFEHEART) an open, multicentre, nation-wide, long-term...

10.1093/eurjpc/zwab185 article EN European Journal of Preventive Cardiology 2021-10-20

Abstract Aims Most heterozygous familial hypercholesterolaemia (FH) patients require intensive lipid-lowering therapy (LLT) including PCSK9 inhibitors (PCSK9is) to reach current low-density lipoprotein cholesterol (LDL-C) goals. Persistence with chronic treatment is important reduce the burden of atherosclerotic cardiovascular disease. We analysed persistence, efficacy, and impact on quality life (QoL) PCSK9i in FH clinical practice setting. Methods results Spanish Familial...

10.1093/eurjpc/zwac277 article EN European Journal of Preventive Cardiology 2022-11-21

Available data regarding clinical profile and management of elderly patients with atrial fibrillation (AF) according to dependency, fragility cognitive impairment are scarce. The objective the study was analyze biodemographic data, antithrombotic treatment in AF patients.Cross-sectional multi-center performed consecutive ≥ 75 years treated oral anticoagulants 3 months attended Internal Medicine Departments Spain.A total 837 (83.0 ± 5.0 years; CHA2DS2-VASc: 1.4; HAS-BLED: 2.1 0.9) were...

10.11909/j.issn.1671-5411.2018.04.004 article EN PubMed 2018-04-01

Malignant syphilis is an infrequent manifestation of in HIV infected patients. Only 21 cases have been published medical literature. Most frequent men, 62%, the mean age presentation 34 years. The most symptoms are: 100% ulcerative cutaneous lesions, 47% fever and 33% ocular affectation. About 80% patients a CD4 count >200. Lues serological test was positive 81% responded to penicillin. We report 18 year old woman diagnosed infection, admitted our service because fever, painful oral sores,...

10.4321/s0212-71992003000700009 article EN Anales de Medicina Interna 2003-07-01

Abstract Background Cardiovascular disease is a major cause of morbidity and mortality in people with HIV. The detection subclinical atherosclerosis through vascular ultrasound allows us to identify patients at an increased risk cardiovascular as primary prevention strategy; this test not routine. Our objective predictors population Methods People HIV infection were selected for underwent carotid femoral detect atheromatous plaques. Logistic regression analysis including factors was...

10.1186/s12879-022-07976-1 article EN cc-by BMC Infectious Diseases 2023-01-10

Around one third to half of patients with hip fractures require red-cell pack transfusion. The increasing incidence fracture has also raised the need for this scarce resource. Additionally, transfusions are not without complications which may involve excessive morbidity and mortality. This makes it necessary develop blood-saving strategies. Our objective was assess safety, efficacy, cost-effictveness combined treatment i.v. ferric carboxymaltose erythropoietin (EPOFE arm) versus (FE a...

10.1186/1471-2474-13-27 article EN cc-by BMC Musculoskeletal Disorders 2012-02-21

BACKGROUND Detecting total cholesterol in dried blood spots could aid identifying individuals with a high likelihood of familial hypercholesterolemia and be used as screening measure. This study aims to assess the diagnostic accuracy on Whatman 903 paper cards using manual enzymatic technique. METHODS A 394 samples collected serum were compared. Cholesterol was determined automated reference method, while measured method. Within- between-day variability analyzed. The correlation between both...

10.20944/preprints202407.0863.v1 preprint EN 2024-07-10

Summary. The significance of Candida albicans in the development denture stomatitis (DS), as well clinical and microbiological efficacy treatment with fluconazole itraconazole was studied 115 patients affected DS 200 controls (100 healthy dental prosthesis 100 without prosthesis). Specimens were taken from all patients; subsequently positive culture group treated fluconazole. A second specimen after 15 days fluconazole, if results again, instituted given appointments for taking a third...

10.1111/j.1439-0507.1997.tb00233.x article IT Mycoses 1997-11-01
Leopoldo Pérez de Isla Raquel Arroyo-Olivares Rodrigo Alonso Ovidio Muñiz-Grijalvo José Luis Díaz-Díaz and 86 more Daniel Zambón Francisco Fuentes Nelva Mata Mar Piedecausa M. Dolores Mañas Juan Francisco Sánchez Muñoz-Torrero José Pablo Miramontes‐González Raimundo de Andrés Marta Mauri Rocío Aguado Ángel Brea José María Cepeda José I. Vidal-Pardo Ceferino Martínez‐Faedo Miguel Ángel Elvira Barba Rosa Argüeso Enrique Ruiz-Pérez Alfredo Michán‐Doña Francisco Arrieta María Riestra Fernández Leire Pérez José Miguel Pinilla Gonzalo Díaz-Soto Xavier Pintó Teresa Padró Lina Badimón Pedro Mata Rocío Aguado Begoña Pérez-Corral Fátima Almagro Rodrigo Alonso Raquel Arroyo Nelva Mata Pedro Mata Leopoldo Pérez de Isla Adriana Saltijeral Francisco Arrieta Lina Badimón Teresa Padró Miguel Ángel Elvira Barba Ángel Brea Daniel Mosquera Marta Casañas Julio Carbayo José María Cepeda Raimundo de Andrés José Luis Díaz-Díaz Gonzalo Díaz-Soto Marta Diéguez María Riestra Fernández Francisco Fuentes José López‐Miranda Jesús Galiana M. Dolores Mañas Jesús García-Cruces Juan Antonio Garrido Luis Irigoyen Pedro L. Martínez Ceferino Martínez‐Faedo Lorena Suárez Marta Mauri Rosa M. Borrallo Juan Diego Mediavilla Fernando Jaén Pablo Jesús Alonso González Alfredo Michán‐Doña Patricia Rubio Pablo Miramontes Juan L. Morera Ovidio Muñiz-Grijalvo A Rodríguez González Francisca Pereyra Leire Pérez Mar Piedecausa J.M. Pastor José Miguel Pinilla Xavier Pintó Manuel Romero Enrique Ruíz M. Pilar Álvarez Pedro Luis Ruíz Sáenz Juan F. Plaza C Sanz Jose I. Vidal Rosa Argüeso Daniel Zambón

10.1016/j.rec.2019.10.028 article ES Revista Española de Cardiología (English Edition) 2020-03-20
Leopoldo Pérez de Isla Raquel Arroyo-Olivares Rodrigo Alonso Ovidio Muñiz-Grijalvo José Luis Díaz-Díaz and 86 more Daniel Zambón Francisco Fuentes Nelva Mata Mar Piedecausa M. Dolores Mañas Juan Francisco Sánchez Muñoz-Torrero José Pablo Miramontes‐González Raimundo de Andrés Marta Mauri Rocío Aguado Ángel Brea José María Cepeda José I. Vidal-Pardo Ceferino Martínez‐Faedo Miguel Ángel Elvira Barba Rosa Argüeso Enrique Ruiz-Pérez Alfredo Michán‐Doña Francisco Arrieta María Riestra Fernández Leire Pérez José Miguel Pinilla Gonzalo Díaz-Soto Xavier Pintó Teresa Padró Lina Badimón Pedro Mata Rocío Aguado Begoña Pérez-Corral Fátima Almagro Rodrigo Alonso Raquel Arroyo Nelva Mata Pedro Mata Leopoldo Pérez de Isla Adriana Saltijeral Francisco Arrieta Lina Badimón Teresa Padró Miguel Ángel Elvira Barba Ángel Brea Daniel Mosquera Marta Casañas Julio Carbayo José María Cepeda Raimundo de Andrés José Luis Díaz-Díaz Gonzalo Díaz-Soto Marta Diéguez María Riestra Fernández Francisco Fuentes José López‐Miranda Jesús Galiana M. Dolores Mañas Jesús García-Cruces Juan Antonio Garrido Luis Irigoyen Pedro L. Martínez Ceferino Martínez‐Faedo Lorena Suárez Marta Mauri Rosa M. Borrallo Juan Diego Mediavilla Fernando Jaén Pablo Jesús Alonso González Alfredo Michán‐Doña Patricia Rubio Pablo Miramontes Juan L. Morera Ovidio Muñiz-Grijalvo A Rodríguez González Francisca Pereyra Leire Pérez Mar Piedecausa J.M. Pastor José Miguel Pinilla Xavier Pintó Manuel Romero Enrique Ruíz M. Pilar Álvarez Pedro Luis Ruíz Sáenz Juan F. Plaza C Sanz Jose I. Vidal Rosa Argüeso Daniel Zambón

10.1016/j.recesp.2019.10.013 article ES Revista Española de Cardiología 2020-01-25
Coming Soon ...